In addition, incretin enthusiasts had suffered a serious disappointment, when it was observed, at about the same time, that GIP although being potently insulinotropic in healthy individuals was ineffective in patients with type 2 diabetes ( not including secretin) also was a potent inhibitor of glucagon secretion ( Inspired by the similarity of GLP-1 with glucagon and oxyntomodulin, it was relevant to look at other glucagon-like gastro-intestinal actions of GLP-1, and via extensive human studies it was soon established that GLP-1 was a physiological and powerful inhibitor of gastrointestinal secretion (both gastric and pancreatic) and motility ( In spite of the disappointment with GIP in T2DM, it was time to see whether the new incretin would have any effects in T2DM patients
For researchers evaluating peptide options for weight loss , the speed factor may be as important as the total magnitude of effect
Research in animal models has demonstrated that GLP-1 activation can enhance serotonin and dopamine signaling, two neurochemicals critical for mood stability
NAD+ is used to convert nutrients into energy and supports cellular repair and longevity
FAQ How is this different from regular vitamin blood tests